drugset
drugset / Trial / NCT00979550

The Effects of Aldara as an Adjunct to Laser Treatment

NCT00979550 ↗

Phase 2 Terminated 7 enrolled Henry Vasconez Graceway Pharmaceuticals, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to determine the effects of Aldara on the cosmetic outcome of laser treatment of vascular malformations.

Timeline

Start
2008-10
Primary completion
2013-08
Completion
2013-08

Outcome

Outcome not reported

Stopped (Enrollment): “Failure to enroll enough participants”

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified — Topical

Indications

capillary malformation